Skip to main content

Staff work in a marijuana grow room at Canopy Growth's Tweed facility in Smiths Falls, Ont.

Sean Kilpatrick/The Canadian Press

Canopy Growth Corp. expects to have about 30 pot-infused products on the market by the end of the year, including distilled cannabis to be used in mixed drinks.

The Smiths Falls, Ont.-based company will start with beverages, edibles and vapes and plans to roll out 32 specific items by end of December, and add 20 more over the following 12 months.

“What you’ll see is our new products will come to market on retail shelves across late December, early January, based on the province,” Canopy president Rade Kovacevic said in an interview.

Story continues below advertisement

Cannabis products such as beverages and topicals became legal on Oct. 17, one year after Canada legalized pot for recreational use.

However, because of the mandatory 60-day notice period that companies must provide to Health Canada before they are able to sell these new pot goods, the earliest they can hit legal shelves is mid-December.

Depending on the province, it will take a bit of time for the new products to be shipped and pass through distribution centres before hitting legal retail shelves, Mr. Kovacevic added.

Cannabis companies have high hopes for these new forms of pot, which have higher margins than existing products and can appeal to a broader base of consumers who aren’t interested in smoking weed.

A recent report by Deloitte estimated that the Canadian market for next-generation pot products was worth an estimated $2.7-billion annually. Roughly $1.6-billion will be spent on edibles, followed by cannabis-infused beverages at $529-million and topicals at $174-million, it said.

Canopy’s biggest investor is Corona beer maker Constellation Brands Inc., which initially acquired 10 per cent of the cannabis company in 2017 for $245-million in a deal that included collaboration on cannabis-based drinks, then later upped its investment by $5-billion.

Other cannabis companies that have partnered with alcohol giants have also started announcing plans for new products containing tetrahydrocannabinol (THC), the compound that produces a high, and cannabidiol (CBD), a non-intoxicating compound.

Story continues below advertisement

Truss Beverages Co., a joint venture between Molson Coors and pot producer Hexo Corp., has developed a CBD-infused spring water and aims to launch various drinks containing THC by the end of the year.

Fluent Beverage Co. – a joint venture between the world’s largest brewer Anheuser-Busch InBev and B.C. pot company Tilray Inc. – said it was launching CBD drinks as early as December, but it was not yet able to develop a formulation for THC, citing stability as a challenge.

Canopy’s next-generation pot goods include its Tweed Distilled Cannabis line, which takes on the flavours of particular cannabis strains.

Mr. Kovacevic said its beverages containing THC and or CBD, which include sparkling waters and ready-made mixed drinks using distilled cannabis, are shelf stable at room temperature.

“We’ve been working on this for years at this point. And so shelf stability was one of the early pieces that was very important for us,” he said.

He added that the drinks’ onset – the time before the active ingredients take effect – would be similar to an alcoholic beverage.

Story continues below advertisement

Canopy’s market research showed that 80 per cent of non-cannabis users would be interested in trying a pot based drink, and it was key to have products geared to new consumers, Mr. Kovacevic said.

“Everyone has heard of someone having a brownie and having a bad experience, getting ahead of that … was very important,” he said.

Potential revenue from the new cannabis products is key given that cannabis companies are coming under more pressure to be profitable.

Constellation said in June that it was “not pleased” with the pot producer’s financial fourth-quarter earnings in which it reported a wider-than-expected loss. Canopy later ousted its co-CEO Bruce Linton in July, and its interim CEO has said it is shifting from “building” mode to “operating mode.”

Earlier this month, cannabis company Hexo Corp. pulled back its fourth-quarter revenue expectations and cut 200 positions, citing industry pressures such as a slow pot-retail rollout. Hexo also launched a one-ounce dried cannabis product with low pricing in a bid to undercut the illicit market shops, and bring in more consumers.

Report an error
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies